1 – 100 of 155
- show: 100
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Structural-functional properties of direct-pathway striatal neurons at early and chronic stages of dopamine denervation
(
- Contribution to journal › Article
-
Mark
Cells, pathways, and models in dyskinesia research
(
- Contribution to journal › Scientific review
- 2023
-
Mark
Distinctive Effects of D1 and D2 Receptor Agonists on Cortico-Basal Ganglia Oscillations in a Rodent Model of L-DOPA-Induced Dyskinesia
(
- Contribution to journal › Article
-
Mark
Comparison of dyskinesia profiles after L-DOPA dose challenges with or without dopamine agonist coadministration
(
- Contribution to journal › Article
-
Mark
Dopamine Agonist Cotreatment Alters Neuroplasticity and Pharmacology of Levodopa-Induced Dyskinesia
(
- Contribution to journal › Article
-
Mark
Ropinirole Cotreatment Prevents Perivascular Glial Recruitment in a Rat Model of L-DOPA-Induced Dyskinesia
(
- Contribution to journal › Article
- 2022
-
Mark
Non‐Apoptotic Caspase‐3 Activation Mediates Early Synaptic Dysfunction of Indirect Pathway Neurons in the Parkinsonian Striatum
(
- Contribution to journal › Article
-
Mark
Non-dopaminergic approaches to the treatment of motor complications in Parkinson's disease
(
- Contribution to journal › Scientific review
- 2021
-
Mark
Toxin-Based Rodent Models of Parkinson’s Disease
(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Distinct patterns of dyskinetic and dystonic features following D1 or D2 receptor stimulation in a mouse model of parkinsonism
(
- Contribution to journal › Article
-
Mark
From iPS Cells to Rodents and Nonhuman Primates : Filling Gaps in Modeling Parkinson's Disease
(
- Contribution to journal › Article
- 2020
-
Mark
D1-mGlu5 heteromers mediate noncanonical dopamine signaling in Parkinson’s disease
(
- Contribution to journal › Article
-
Mark
Preface : The evolving scenario of Parkinson's research
(
- Chapter in Book/Report/Conference proceeding › Foreword/Postscript
-
Mark
Cortico-Striatal Oscillations Are Correlated to Motor Activity Levels in Both Physiological and Parkinsonian Conditions
(
- Contribution to journal › Article
-
Mark
Dyskinesia matters
(
- Contribution to journal › Article
-
Mark
Animal models for preclinical Parkinson´s research: An update and critical appraisal
(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Tracking Rats in Operant Conditioning Chambers Using a Versatile Homemade Video Camera and DeepLabCut
2020) In Journal of visualized experiments : JoVE(
- Contribution to journal › Article
-
Mark
Reply to : Letter to Editor by Chaudhuri, Jenner, Antonini
(
- Contribution to journal › Letter
-
Mark
The role of glia in Parkinson's disease : Emerging concepts and therapeutic applications
(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2019
-
Mark
Significance and translational value of high-frequency cortico-basal ganglia oscillations in Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Pridopidine Induces Functional Neurorestoration Via the Sigma-1 Receptor in a Mouse Model of Parkinson’s Disease
(
- Contribution to journal › Article
-
Mark
Seeding of protein aggregation causes cognitive impairment in rat model of cortical synucleinopathy
(
- Contribution to journal › Article
- 2018
-
Mark
mGlu receptors in the treatment of Parkinson's disease and L-DOPA-induced dyskinesia
(
- Contribution to journal › Scientific review
-
Mark
Striatonigral neurons divide into two distinct morphological-physiological phenotypes after chronic L-DOPA treatment in parkinsonian rats
(
- Contribution to journal › Article
-
Mark
Animal models of l-dopa-induced dyskinesia in Parkinson's disease
(
- Contribution to journal › Scientific review
-
Mark
Progressive striatonigral degeneration in a transgenic mouse model of multiple system atrophy : translational implications for interventional therapies
(
- Contribution to journal › Article
-
Mark
On the neuronal circuitry mediating l-DOPA-induced dyskinesia
(
- Contribution to journal › Article
- 2017
-
Mark
Differential effects of gaseous versus injectable anesthetics on changes in regional cerebral blood flow and metabolism induced by l-DOPA in a rat model of Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Molecular Mechanisms of L-DOPA-Induced Dyskinesia
(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Chemogenetic stimulation of striatal projection neurons modulates responses to Parkinson's disease therapy
(
- Contribution to journal › Article
-
Mark
CK2 oppositely modulates L-DOPA-induced dyskinesia via striatal projection neurons expressing D1 or D2 receptors
(
- Contribution to journal › Article
-
Mark
Levodopa-induced abnormal involuntary movements correlate with altered permeability of the blood-brain-barrier in the basal ganglia
(
- Contribution to journal › Article
-
Mark
Translating scientific advances into disease-modifying therapies for Parkinson's Disease
(
- Contribution to journal › Article
-
Mark
Neuroprotection and neurorestoration as experimental therapeutics for Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Alterations of striatal indirect pathway neurons precede motor deficits in two mouse models of Huntington's disease
(
- Contribution to journal › Article
-
Mark
Etiology and pathogenesis of parkinson’s disease
2017) p.95-101(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2016
-
Mark
Gene therapy blockade of dorsal striatal p11 improves motor function and dyskinesia in parkinsonian mice.
(
- Contribution to journal › Article
-
Mark
On the Effect of Eltoprazine in Dyskinetic Hemiparkinsonian Rats.
(
- Contribution to journal › Letter
-
Mark
Validation of an improved scale for rating L-DOPA-induced dyskinesia in the mouse and effects of specific dopamine receptor antagonists
(
- Contribution to journal › Article
-
Mark
Dissociation of metabolic and hemodynamic levodopa responses in the 6-hydroxydopamine rat model
(
- Contribution to journal › Article
-
Mark
Dramatic differences in susceptibility to L-DOPA-induced dyskinesia between mice that are aged before or after a nigrostriatal dopamine lesion
(
- Contribution to journal › Article
-
Mark
Oral and infusion levodopa therapy in the management of Parkinson’s disease
2016) p.63-75(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Signaling mechanisms in L-DOPA-induced dyskinesia
2016) p.155-188(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2015
-
Mark
A Genetic Mouse Model of Parkinson's Disease Shows Involuntary Movements and Increased Postsynaptic Sensitivity to Apomorphine
(
- Contribution to journal › Article
-
Mark
Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease.
(
- Contribution to journal › Scientific review
-
Mark
Activity of serotonin 5-HT1A receptor 'biased agonists' in rat models of Parkinson's disease and l-DOPA-induced dyskinesia.
(
- Contribution to journal › Article
-
Mark
Zooming in on the small: The plasticity of striatal dendritic spines in l-DOPA-Induced dyskinesia.
(
- Contribution to journal › Article
-
Mark
Rodent models of impulsive compulsive behaviors in Parkinson's disease: how far have we reached?
(
- Contribution to journal › Scientific review
-
Mark
M4 Muscarinic Receptor Signaling Ameliorates Striatal Plasticity Deficits in Models of L-DOPA-Induced Dyskinesia.
(
- Contribution to journal › Article
-
Mark
NLX-112, a novel 5-HT1A receptor agonist for the treatment of L-DOPA-induced dyskinesia: Behavioral and neurochemical profile in rat.
(
- Contribution to journal › Article
-
Mark
Increased CSF biomarkers of angiogenesis in Parkinson disease.
(
- Contribution to journal › Article
-
Mark
Pharmacological stimulation of metabotropic glutamate receptor type 4 in a rat model of Parkinson's disease and l-DOPA-induced dyskinesia: Comparison between a positive allosteric modulator and an orthosteric agonist.
(
- Contribution to journal › Article
- 2014
-
Mark
Cell type-specific plasticity of striatal projection neurons in parkinsonism and L-DOPA-induced dyskinesia.
(
- Contribution to journal › Article
-
Mark
Mechanisms of Dopamine D1 Receptor-Mediated ERK1/2 Activation in the Parkinsonian Striatum and Their Modulation by Metabotropic Glutamate Receptor Type 5.
2014) In The Journal of Neuroscience : the official journal of the Society for Neuroscience 34(13). p.4728-4740(
- Contribution to journal › Article
-
Mark
Pharmacological stimulation of sigma-1 receptors has neurorestorative effects in experimental parkinsonism.
(
- Contribution to journal › Article
-
Mark
Glutamatergic pathways as a target for the treatment of dyskinesias in Parkinson's disease.
(
- Contribution to journal › Article
-
Mark
Chapter 22 - Rodent Models of Treatment-Related Complications in Parkinson Disease
2014) p.373-386(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Molecular adaptations of striatal spiny projection neurons during levodopa-induced dyskinesia
2014) In Proceedings of the National Academy of Sciences of the United States of America 111(12). p.4578-4583(
- Contribution to journal › Article
-
Mark
Preclinical models of levodopa-induced dyskinesia
2014) p.335-353(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Investigating the molecular mechanisms of L-DOPA-induced dyskinesia in the mouse
(
- Contribution to journal › Article
-
Mark
Presynaptic Mechanisms of l-DOPA-Induced Dyskinesia: The Findings, the Debate, and the Therapeutic Implications.
(
- Contribution to journal › Scientific review
- 2013
-
Mark
Bad News for Neuroprotective Therapies in PD?
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Region-specific restoration of striatal synaptic plasticity by dopamine grafts in experimental parkinsonism.
(
- Contribution to journal › Article
-
Mark
Modulating mGluR5 and 5-HT1A/1B receptors to treat l-DOPA-induced dyskinesia: Effects of combined treatment and possible mechanisms of action.
(
- Contribution to journal › Article
- 2012
-
Mark
Glutamatergic mechanisms in the dyskinesias induced by pharmacological dopamine replacement and deep brain stimulation for the treatment of Parkinson's disease
(
- Contribution to journal › Scientific review
-
Mark
Levodopa-induced dyskinesia is strongly associated with resonant cortical oscillations.
2012) In The Journal of Neuroscience : the official journal of the Society for Neuroscience 32(47). p.16541-16551(
- Contribution to journal › Article
-
Mark
In vivo evidence for a differential contribution of striatal and nigral D1 and D2 receptors to l-DOPA induced dyskinesia and the accompanying surge of nigral amino acid levels
(
- Contribution to journal › Article
-
Mark
A Model of GDNF Gene Therapy in Mice with 6-Hydroxydopamine Lesions: Time Course of Neurorestorative Effects and ERK1/2 Activation
(
- Contribution to journal › Article
-
Mark
Impact of L-DOPA treatment on regional cerebral blood flow and metabolism in the basal ganglia in a rat model of Parkinson's disease.
(
- Contribution to journal › Article
- 2011
-
Mark
The locus coeruleus Is Directly Implicated in L-DOPA-Induced Dyskinesia in Parkinsonian Rats: An Electrophysiological and Behavioural Study
(
- Contribution to journal › Article
-
Mark
Impact of the lesion procedure on the profiles of motor impairment and molecular responsiveness to L-DOPA in the 6-hydroxydopamine mouse model of Parkinson's disease.
(
- Contribution to journal › Article
-
Mark
Parkinson disease: Poor results for retinal cell transplants in Parkinson disease.
(
- Contribution to journal › Article
-
Mark
Current Options and Future Possibilities for the Treatment of Dyskinesia and Motor Fluctuations in Parkinson's Disease
(
- Contribution to journal › Article
-
Mark
Putaminal Upregulation of FosB/Delta FosB-Like Immunoreactivity in Parkinson's Disease Patients with Dyskinesia
(
- Contribution to journal › Article
-
Mark
Vascular endothelial growth factor is upregulated by L-dopa in the parkinsonian brain: implications for the development of dyskinesia.
(
- Contribution to journal › Article
-
Mark
Apoptosis-inducing factor mediates dopaminergic cell death in response to lps-induced inflammatory stimulus Evidence in Parkinson's disease patients.
(
- Contribution to journal › Article
-
Mark
Mechanisms underlying cortical resonance in levodopa-induced dyskinesia
2011) Annual Meeting of Society for Neuroscience 2011(Neuroscience 2011)(
- Contribution to conference › Abstract
-
Mark
Cortical resonance around 80 Hz is linked to dyskinesia after levodopa treatment in a rodent model of Parkinson’s disease
2011) Annual Meeting of Society for Neuroscience 2011(Neuroscience 2011)(
- Contribution to conference › Abstract
-
Mark
In vivo microdialysis studies of striatal dopamine efflux and its relationship to L-DOPA-induced dyskinesia in mouse models of Parkinson's disease.
2011) 41st Annual Meeting of the Society-for-Neuroscience(
- Contribution to conference › Abstract
- 2010
-
Mark
Recent Advances In Parkinson'S Disease: Translational And Clinical Research Preface
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Calcium-permeable AMPA receptors are involved in the induction and expression of l-DOPA-induced dyskinesia in Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Deuterium substitutions in the L-DOPA molecule improve its anti-akinetic potency without increasing dyskinesias
(
- Contribution to journal › Article
-
Mark
Post- Versus Pre-Synaptic Plasticity
(
- Contribution to journal › Published meeting abstract
-
Mark
Immunohistochemical Detection of Fosb/Delta fosb-Like Proteins Maps Areas of Maladaptive Neuroplasticity in the Post-Mortem Parkinsonian Brain
(
- Contribution to journal › Published meeting abstract
-
Mark
Inhibition of Ras-guanine nucleotide-releasing factor 1 (Ras-GRF1) signaling in the striatum reverts motor symptoms associated with L-dopa-induced dyskinesia.
(
- Contribution to journal › Article
-
Mark
A mGluR5 antagonist under clinical development improves L-DOPA-induced dyskinesia in parkinsonian rats and monkeys.
(
- Contribution to journal › Article
-
Mark
Maladaptive striatal plasticity in L-DOPA-induced dyskinesia.
(
- Contribution to journal › Scientific review
-
Mark
L-DOPA-induced dopamine efflux in the striatum and the substantia nigra in a rat model of Parkinson's disease: temporal and quantitative relationship to the expression of dyskinesia.
(
- Contribution to journal › Article
-
Mark
Maladaptive plasticity of serotonin axon terminals in levodopa-induced dyskinesia.
(
- Contribution to journal › Article
-
Mark
Recent advances in Parkinson's disease : basic research. Preface
(
- Contribution to journal › Article
-
Mark
6-OH Dopamine Rat Model
2010) p.3-5(
- Chapter in Book/Report/Conference proceeding › Entry for encyclopaedia/dictionary
-
Mark
Climbing behaviour
2010) p.26-27(
- Chapter in Book/Report/Conference proceeding › Entry for encyclopaedia/dictionary
-
Mark
Tail-pinch stimulus
2010) p.209-210(
- Chapter in Book/Report/Conference proceeding › Entry for encyclopaedia/dictionary
-
Mark
Preface
(
- Chapter in Book/Report/Conference proceeding › Foreword/Postscript
-
Mark
Differential molecular and behavioural response to L-DOPA in mice injected with 6-hydroxydopamine in the striatum or in the medial forebrain bundle
2010)(
- Contribution to conference › Poster
-
Mark
Dyskinesia - Advances in the understanding of pathophysiology and possible treatment options
(
- Contribution to journal › Article
- 2009
-
Mark
Differential Involvement of D1 and D2 Dopamine Receptors in L-DOPA-Induced Angiogenic Activity in a Rat Model of Parkinson's Disease.
(
- Contribution to journal › Article
-
Mark
Antagonizing L-type Ca2+ Channel Reduces Development of Abnormal Involuntary Movement in the Rat Model of L-3,4-Dihydroxyphenylalanine-Induced Dyskinesia
(
- Contribution to journal › Article
-
Mark
Pharmacological modulation of glutamate transmission in a rat model of L-DOPA-induced dyskinesia: effects on motor behavior and striatal nuclear signalling.
(
- Contribution to journal › Article
-
Mark
Chronic intermittent L-DOPA treatment induces changes in dopamine release
(
- Contribution to journal › Article